MilgoSense

AI-based Diagnostic Tool for Schizophrenia

Health Tech & Life Sciences
Active
Pre-Funding Kiryat Ono, Israel Founded 2023
Last updated 2026-06-18
Total raised
Stage
Pre-Funding
Founded
2023
Headcount
1
HQ
Kiryat Ono, Israel
Sector
Health Tech & Life Sciences

About

MilgoSense is an early-stage venture that seeks to disrupt the future of schizophrenia diagnosis, monitoring, and decision-making using simple, non-invasive, cheap, remote and AI-based diagnostic tool.

Schizophrenia is a severe, chronic, and disabling mental disorder affecting approximately 1.1% of the population worldwide. It represents a significant economic burden for patients, payers, and society. Current annual US healthcare estimated costs exceed $155B. It usually starts in teenagers, where the symptoms are confusing and not easy to differentiate from somewhat more typical states of mind at this age. Early diagnosis and treatment may help get symptoms under control and may reduce the need for costly long-term hospitalizations. Early treatment entry may reduce hospitalizations and increase independent living by 41.5–46% and employment by 42–58%.

The fundamental unmet need the company wish to address is the lack of an objective decision-support tool to help prioritize and bring those teenagers in distress as soon as possible to a trained psychiatrist before it is too late.

Q&A

What is MilgoSense's primary focus?
MilgoSense is developing an AI-based diagnostic tool for schizophrenia, aiming to disrupt its diagnosis, monitoring, and decision-making processes.
When was MilgoSense founded?
MilgoSense was founded in December 2023.
Where is MilgoSense headquartered?
MilgoSense is headquartered in Kiryat Ono, Center District, Israel.
What problem does MilgoSense aim to solve?
MilgoSense aims to address the lack of an objective decision-support tool for early diagnosis of schizophrenia in teenagers, which can lead to better treatment outcomes and reduced hospitalizations.
What is the current employee count for MilgoSense?
MilgoSense has 1-10 employees.
Who is the founder and CEO of MilgoSense?
Dovi Kelman is the Founder & CEO of MilgoSense.
What is MilgoSense's current funding stage?
MilgoSense is currently in the Pre-Funding stage.
What sector does MilgoSense primarily operate in?
MilgoSense primarily operates in the Health Tech & Life Sciences sector.

Team · 1

Founder · Founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical Diagnostics
Technologies
Artificial Intelligence
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

Verified

Tags

digital-healthcarediagnosticsmental-healthartificial-intelligence
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitemilgosense.com/
LinkedInlinkedin.com/company/101539487

Identifiers & details

Founded2023-12
Employees (exact)1

Radar intelligence

Web history (Wayback)

Domainmilgosense.com

Certificate / subdomain footprint

Subdomains2